lung disease
Information
- Disease name
- lung disease
- Disease ID
- DOID:850
- Description
- "A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide." [url:http\://www.niehs.nih.gov/health/topics/conditions/lung-disease/index.cfm, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000066.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03085069 | Active, not recruiting | Phase 2 | A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC | May 3, 2017 | August 20, 2023 |
NCT00013780 | Completed | Ozone Exposure and Dose Delivered to Human Lungs | July 1998 | June 2003 | |
NCT00013949 | Completed | Cardiovascular Vulnerability to Particulate Exposure | September 1998 | September 2004 | |
NCT00014950 | Completed | N/A | Benefits and Risks of Newborn Screening for Cystic Fibrosis | ||
NCT00014963 | Completed | Biomarkers of Benzene Exposure in Inner City Residents | |||
NCT02234128 | Completed | N/A | Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility | July 18, 2015 | November 7, 2019 |
NCT00131274 | Completed | Phase 2/Phase 3 | Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study | April 2003 | August 2007 |
NCT00139152 | Completed | Phase 4 | Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair | September 2005 | December 2009 |
NCT00224198 | Completed | Evaluation of the Lungs of Individuals With Lung Disease | January 2004 | September 2012 | |
NCT00315263 | Completed | Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology | April 2006 | July 2011 | |
NCT00455767 | Completed | Phase 2 | Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients | July 2006 | September 2007 |
NCT00504738 | Completed | Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease | April 2006 | April 2007 | |
NCT00551642 | Completed | Phase 3 | Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies | May 29, 2005 | July 17, 2015 |
NCT00704171 | Completed | Phase 4 | PleuraSeal Post Market Study (Europe) | January 2008 | December 2008 |
NCT00760071 | Completed | Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF) | July 2006 | September 2009 | |
NCT00817167 | Completed | N/A | Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy | January 2009 | December 2009 |
NCT00818025 | Completed | N/A | Comparing Methods for Tracking Health Information at Home After Lung Transplant | January 2009 | January 2013 |
NCT00837681 | Completed | Pulmonary Complications of Hematopoietic Stem Cell Transplantation | October 2005 | July 8, 2016 | |
NCT00843414 | Completed | Immunological Characterization of Bronchoalveolar Cells in Normals | March 1978 | April 2011 | |
NCT00934778 | Completed | N/A | Minimally Invasive Endoscopy in Diffuse Lung Disease | June 2009 | November 2016 |
NCT01107054 | Completed | Phase 1 | A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers | June 2010 | December 2010 |
NCT01153321 | Completed | Phase 2 | Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) | October 2010 | July 2011 |
NCT01184118 | Completed | N/A | DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations? | March 2009 | February 2011 |
NCT01215279 | Completed | Phase 2 | AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) | October 2010 | March 2011 |
NCT01222442 | Completed | Phase 1 | To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart | November 2010 | February 2011 |
NCT01255592 | Completed | Phase 2 | Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis | February 2011 | February 2012 |
NCT01289327 | Completed | N/A | Propofol Versus Midazolam+Alfentanil for Sedation During Bronchoscopy: Comparison by Cutaneous Carbon Dioxide Tension | April 2010 | January 2011 |
NCT01404780 | Completed | N/A | Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation | June 2011 | February 2013 |
NCT01679301 | Completed | N/A | Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator | September 2012 | July 2014 |
NCT01735526 | Completed | Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation | October 2012 | June 2013 | |
NCT01952002 | Completed | Clinical Safety for the Inspiratory Muscle Training | October 2012 | June 2013 | |
NCT02055222 | Completed | Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease | October 14, 2014 | August 23, 2018 | |
NCT02112929 | Completed | Phase 1 | Regional Lung Imaging Using Hyperpolarized Xenon Gas | April 2012 | September 30, 2021 |
NCT02217423 | Completed | N/A | Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical Therapy | September 2014 | December 2015 |
NCT00001303 | Completed | Phase 1 | Effects of Endotoxin in Normal Human Volunteers | April 6, 1992 | May 17, 2018 |
NCT02345135 | Completed | N/A | Susceptibility to Infections in Ataxia Telangiectasia | September 2012 | July 31, 2016 |
NCT02804854 | Completed | Phase 2 | Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit | December 2016 | July 2022 |
NCT02887820 | Completed | N/A | Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO) | December 15, 2017 | December 31, 2023 |
NCT00052052 | Completed | Phase 2 | An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) | September 2002 | September 2004 |
NCT02946658 | Enrolling by invitation | Phase 1/Phase 2 | Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders | October 2016 | August 14, 2025 |
NCT00001465 | Recruiting | Study of the Disease Process of Lymphangioleiomyomatosis | December 18, 1995 | ||
NCT00077909 | Recruiting | Study of Lung Proteins in Patients With Pneumonia | February 20, 2004 | ||
NCT02723474 | Recruiting | N/A | A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease | November 2007 | October 2025 |
NCT02723500 | Recruiting | N/A | 129 Xenon MRI in Chronic Lung Disease | August 2011 | December 2025 |
NCT05933694 | Recruiting | N/A | Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software | June 27, 2023 | September 30, 2024 |
NCT00041548 | Terminated | Phase 1/Phase 2 | Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation | May 2002 | June 2005 |
NCT00041574 | Terminated | Phase 2 | Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide | April 2002 | December 2005 |
NCT00052039 | Terminated | Phase 3 | A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone | April 2002 | June 2002 |
NCT00075179 | Terminated | Phase 4 | Natrecor in Pulmonary Hypertension | December 31, 2003 | March 28, 2006 |
NCT00075998 | Terminated | Phase 3 | The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) | December 2003 | May 2007 |
NCT00076635 | Terminated | Phase 3 | An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF | November 2003 | April 2007 |
NCT00751309 | Terminated | Lung Allograft Rejection Gene Expression Observational (LARGO) Study | April 2004 | January 2009 | |
NCT02168036 | Terminated | Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease. | August 16, 2011 | February 16, 2017 | |
NCT02188511 | Terminated | N/A | Effects of Electronic Cigarettes on Lung Biology | January 2014 | July 2018 |
NCT02204202 | Terminated | PET Assessment of Acute Lung Transplant Rejection | February 2014 | February 4, 2017 | |
NCT00966823 | Terminated | Phase 2 | Fetal Tracheal Balloon Study in Diaphragmatic Hernia | September 2008 | January 2015 |
NCT02464280 | Terminated | Tomosynthesis of Pathologies of the Chest and Skeletal Structures in Comparison to CT | May 2016 | October 2020 | |
NCT01241617 | Terminated | N/A | ENDO GIA Stapler With Duet Tissue Reinforcement System (TRS) Used in Pulmonary Resections | August 2010 | January 2012 |
NCT01450644 | Unknown status | Phase 2 | Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease | October 2011 | January 2013 |
NCT02965300 | Unknown status | The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis | October 2016 | August 2017 | |
NCT03017976 | Unknown status | Swimming Pool Environment Impact on the Human Respiratory Health | January 2017 | July 2018 | |
NCT02191410 | Unknown status | Phase 3 | Nondependent Lung Ventilation and Fluid Responsiveness | January 2019 | June 2020 |
NCT01090804 | Unknown status | Phase 2/Phase 3 | The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance | August 2009 | |
NCT02963467 | Unknown status | N/A | Effect of Smoking on Ventilation-Perfusion Ratio | September 17, 2018 | September 2019 |
NCT02699268 | Unknown status | A Clinical Study Aiming to Validate the Equipment: VoluSense Pediatrics (VSP) | December 2015 | March 2016 | |
NCT03816059 | Unknown status | Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications | February 12, 2019 | April 20, 2020 | |
NCT02913365 | Unknown status | Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis | October 2012 | June 2017 | |
NCT00618852 | Unknown status | Phase 3 | Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates | January 2007 | June 2009 |
NCT02000206 | Unknown status | N/A | Comparison of Propofol/Alfentanil With Propofol/Ketamine | February 2014 | December 2014 |
NCT02253667 | Withdrawn | N/A | Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients | September 2014 | September 2015 |
NCT01457443 | Withdrawn | Biomarker for Pompe Disease (BioPompe) | August 20, 2018 | December 31, 2021 |
- Disase is a (Disease Ontology)
- DOID:0050161
- Cross Reference ID (Disease Ontology)
- ICD10CM:J98.4
- Cross Reference ID (Disease Ontology)
- MESH:D008171
- Cross Reference ID (Disease Ontology)
- NCI:C3198
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266374002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0024115